Primary Sjogren's syndrome: The challenge for classification of disease manifestations

被引:39
作者
Oxholm, P
Asmussen, K
机构
[1] Div. Med. Rheumatology and Immunol., RHIMA Centre, National University Hospital, Copenhagen
[2] Medical Department TA, RHIMA Centre 7562, National University Hospital, DK-2200 Copenhagen N
关键词
classification criteria; disease manifestations; Sjogren's syndrome;
D O I
10.1046/j.1365-2796.1996.482818000.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A new model for classifying the clinical disease manifestations of primary Sjogren's syndrome is introduced. Three 'exocrine' and four 'nonexocrine' subgroups of disease manifestations are defined. Accordingly, 'surface exocrine disease' includes the diagnostic features from eyes, mouth, and the manifestations from the upper airways, skin and genital tract. Involvement of the excretory parenchyma of the lungs, hepatobiliary system, pancreas, gastro-intestinal tract and kidneys is designated 'internal organ exocrine disease'. We suggest 'monoclonal B lymphocyte disease' to be an exocrine disease manifestation because it originates mostly from the immunoinflammatory foci of the autoimmune exocrinopathy. The nonexocrine manifestations are subgrouped into 'inflammatory vascular disease', 'noninflammatory vascular disease', 'mediator-induced disease' and 'autoimmune endocrine disease'.
引用
收藏
页码:467 / 474
页数:8
相关论文
共 38 条
[31]  
TALAL N, 1987, SJOGRENS SYNDROME CL
[32]  
Tzioufas AG., 1987, SJ GRENS SYNDROME CL, P129, DOI [10.1007/978-3-642-50118-0_13, DOI 10.1007/978-3-642-50118-0_13]
[33]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SJOGRENS-SYNDROME - RESULTS OF A PROSPECTIVE CONCERTED ACTION SUPPORTED BY THE EUROPEAN COMMUNITY [J].
VITALI, C ;
BOMBARDIERI, S ;
MOUTSOPOULOS, HM ;
BALESTRIERI, G ;
BENCIVELLI, W ;
BERNSTEIN, RM ;
BJERRUM, KB ;
BRAGA, S ;
COLL, JQ ;
DEVITA, S ;
DROSOS, AA ;
EHRENFELD, M ;
HATRON, PY ;
HAY, EM ;
ISENBERG, DA ;
JANIN, A ;
KALDEN, JR ;
KATER, L ;
KONTTINEN, YT ;
MADDISON, PJ ;
MAINI, RN ;
MANTHORPE, R ;
MEYER, O ;
OSTUNI, P ;
PENNEC, Y ;
PRAUSE, JU ;
RICHARDS, A ;
SAUVEZIE, B ;
SCHIODT, M ;
SCIUTO, M ;
SCULLY, C ;
SHOENFELD, Y ;
SKOPOULI, FN ;
SMOLEN, JS ;
SNAITH, ML ;
TISHLER, M ;
TODESCO, S ;
VALESINI, G ;
VENABLES, PJW ;
WATTIAUX, EJ ;
YOUINOU, P .
ARTHRITIS AND RHEUMATISM, 1993, 36 (03) :340-347
[34]  
WHALEY K, 1989, TXB RHEUMATOLOGY, P999
[35]  
1980, ANN INTERN MED, V92, P212
[36]  
1986, SCAND J RHEUMATOL S, V61
[37]  
1984, LANCET, P730
[38]  
1989, CLIN EXP RHEUMATOL, V7, P211